tiprankstipranks
Luye Pharma Group Ltd. (HK:2186)
:2186
Hong Kong Market
2186
Luye Pharma Group
RESEARCH TOOLSreports
Want to see HK:2186 full AI Analyst Report?

Luye Pharma Group (2186) Income Statement

3 Followers

Luye Pharma Group Income Statement

Last quarter (Q4 2025), Luye Pharma Group's total revenue was ¥3.13B, a decrease of -3.45% from the same quarter last year. In Q4, Luye Pharma Group's net income was ¥305.86M. See Luye Pharma Group’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
¥ 6.31B¥ 6.06B¥ 6.14B¥ 5.98B¥ 5.20B
Gross Profit
¥ 4.16B¥ 4.04B¥ 4.20B¥ 4.14B¥ 3.40B
Operating Expenses
¥ 2.92B¥ 2.90B¥ 3.29B¥ 3.26B¥ 2.96B
Depreciation and Amortization
¥ 796.74M¥ 665.47M¥ 701.85M¥ 671.31M¥ 581.98M
EBITDA
¥ 2.01B¥ 1.79B¥ 2.08B¥ 1.81B¥ 906.88M
Operating Income
¥ 1.24B¥ 1.15B¥ 917.88M¥ 880.62M¥ 437.96M
Other Income/Expenses
¥ -298.24M¥ -308.03M¥ -217.78M¥ -210.86M¥ 0.00
Pretax Income
¥ 944.64M¥ 839.22M¥ 700.10M¥ 669.76M¥ -74.56M
Net Income
¥ 618.75M¥ 471.89M¥ 532.61M¥ 604.81M¥ -134.39M
Per Share Metrics
Basic EPS
¥ 0.16¥ 0.13¥ 0.14¥ 0.17¥ -0.04
Diluted EPS
¥ 0.16¥ 0.13¥ 0.14¥ 0.17¥ -0.04
Weighted Average Shares Outstanding
 3.90B 3.76B 3.73B 3.48B 3.45B
Weighted Average Shares Outstanding (Diluted)
 3.90B 3.76B 3.73B 3.48B 3.45B
Currency in CNY

Luye Pharma Group Earnings and Revenue History